-
-
Call more information
660-596-2224 -
ASA Monitor August 2022, Vol. 86 We read with great interest the April 2022 Monitor article by Hardman et al. that evaluated the use and reliability of rocuronium and succinylcholine as rapid-onset neuromuscular blocking agents (NMBAs) during induction (ASA Monitor 2022;86:42). The authors appropriately discuss the inverse relationship between the molar potency of NMBAs and their speed […]
Read MoreAuthors: Nicholas V. Mendez, MD ASA Monitor August 2022, Vol. 86, 38. The field of anesthesia for abdominal organ transplantation is rapidly expanding as the need for liver, intestine, kidney, and pancreas transplants increases and the complexity of the patients eligible to undergo these operations continues to grow. Fellowship training in liver and abdominal transplant anesthesia […]
Read MoreAuthor: Michael E. Harned, MD, FASA ASA Monitor August 2022, Vol. 86, 29. The opioid crisis continues to spiral. Today, Americans are more likely to die from an accidental opioid overdose (1 in 96 odds) than a car crash (1 in 103 odds) (asamonitor.pub/3xncIyB). Crafting solutions calibrated to truly meet the severity of the crisis isn’t […]
Read MoreASA Monitor August 2022, Vol. 86, 16. A patient presents to the emergency department with newly diagnosed type A aortic dissection. You prepare to take the patient to the OR emergently. The patient is hypertensive in the emergency department with a blood pressure of 180/90 mm Hg and a heart rate of 90 beats/min. Which of […]
Read MoreASA Monitor August 2022, Vol. 86, 27–28. Media coverage of ASA’s fight against 0% increase in Medicare payment continues In March, Becker’s ASC Review covered ASA’s urging Congress not to accept the Medicare Payment Advisory Commission Recommendation of no (0%) annual payment update for physician payments in 2023 and quoted ASA President Randall M. Clark, MD, […]
Read More